Clarity emerges on Indian health ministry’s pharma trademarks directive
Towards the end of last year, reports emerged from India suggesting that regulatory authorities in the country might be planning to restrict or even ban the use of brand names in the sale of pharmaceutical products. However, as more detail has emerged it is apparent the move is not the threat to trademarks that some speculated.
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the WTR experts.